Dynamic Visualization of Computer-Aided Peptide Design for Cancer Therapeutics

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2025 Feb 20

PMID 39974609

Authors

Dan Hou

Haobin Zhou

Yuting Tang

Ziyuan Liu

Lin Su

Junkai Guo

Janak Lal Pathak

Lihong Wu

Affiliations

Soon will be listed here.

Abstract

Purpose: Cancer stands as a significant global public health concern, with traditional therapies potentially yielding severe side effects. Peptide-based cancer therapy is increasingly employed for diseases like cancer due to its advantages of excellent targeting, biocompatibility, and convenient synthesis. With advancements in computer technology and bioinformatics, rational design strategies based on computer technology have been employed to develop more cost-effective and potent anticancer peptides (ACPs). This study aims to explore the current status, hotspots, and future trends in the field of computer-aided design of peptides for cancer treatment through a bibliometric analysis.

Methods: A total of 1547 relevant publications published from 2006 to 2024 were collected from the Web of Science Core Collection. Bibliometric analysis was conducted using tools like CiteSpace, VOSviewer, Bibliometrix, Origin, and an online bibliometric platform.

Results: The research in this field has shown a steady growth trend, with the United States and China making the most significant contributions. Currently, ACP research mainly focuses on cell-penetrating peptides related to drug delivery, which are expected to become future research hotspots. Beyond that, peptide vaccines associated with immunotherapy are also worthy of attention. In addition, molecular dynamics simulation and molecular docking are currently popular research methods. At the same time, deep learning is the emerging keyword, indicating its potential for a more significant impact on future peptide design.

Conclusion: Deep learning technology represents emerging research hotspots with immense potential and promising prospects. As cutting-edge research directions, cellularly penetrating peptides and polypeptide immunotherapy are expected to achieve breakthroughs in cancer treatment. This study provides valuable insights into the computer-aided design of peptides in cancer therapy, contributing significantly to advancing the in-depth research and applications in this area.

References

Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View

Deng Y, Ma S, Li J, Zheng B, Lv Z . Using the Random Forest for Identifying Key Physicochemical Properties of Amino Acids to Discriminate Anticancer and Non-Anticancer Peptides. Int J Mol Sci. 2023; 24(13). PMC: 10341712. DOI: 10.3390/ijms241310854. View

Singh S, Utreja D, Kumar V . Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy. Med Chem Res. 2021; 31(1):1-25. PMC: 8590428. DOI: 10.1007/s00044-021-02819-1. View

Feng G, Yao H, Li C, Liu R, Huang R, Fan X . ME-ACP: Multi-view neural networks with ensemble model for identification of anticancer peptides. Comput Biol Med. 2022; 145:105459. DOI: 10.1016/j.compbiomed.2022.105459. View

Yang Y, Chen H, Hao H, Wang K . The Anticancer Activity Conferred by the Mud Crab Antimicrobial Peptide Scyreprocin through Apoptosis and Membrane Disruption. Int J Mol Sci. 2022; 23(10). PMC: 9142079. DOI: 10.3390/ijms23105500. View

Pirtskhalava M, Amstrong A, Grigolava M, Chubinidze M, Alimbarashvili E, Vishnepolsky B . DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res. 2020; 49(D1):D288-D297. PMC: 7778994. DOI: 10.1093/nar/gkaa991. View

Kong X, Xu J, Yang X, Zhai Y, Ji J, Zhai G . Progress in tumour-targeted drug delivery based on cell-penetrating peptides. J Drug Target. 2021; 30(1):46-60. DOI: 10.1080/1061186X.2021.1920026. View

Singh S, Chaudhary K, Dhanda S, Bhalla S, Usmani S, Gautam A . SATPdb: a database of structurally annotated therapeutic peptides. Nucleic Acids Res. 2015; 44(D1):D1119-26. PMC: 4702810. DOI: 10.1093/nar/gkv1114. View

Iksen I, Witayateeraporn W, Wirojwongchai T, Suraphan C, Pornputtapong N, Singharajkomron N . Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments. Sci Rep. 2023; 13(1):1545. PMC: 9883450. DOI: 10.1038/s41598-023-28821-8. View

10.

Vidal-Limon A, Aguilar-Toala J, Liceaga A . Integration of Molecular Docking Analysis and Molecular Dynamics Simulations for Studying Food Proteins and Bioactive Peptides. J Agric Food Chem. 2022; 70(4):934-943. DOI: 10.1021/acs.jafc.1c06110. View

11.

Nickols N, Goetz M, Graber C, Bhattacharya D, Soo Hoo G, Might M . Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized.... Trials. 2021; 22(1):431. PMC: 8256647. DOI: 10.1186/s13063-021-05389-0. View

12.

Wang M, Liu J, Xia M, Yin L, Zhang L, Liu X . Peptide-drug conjugates: A new paradigm for targeted cancer therapy. Eur J Med Chem. 2024; 265:116119. DOI: 10.1016/j.ejmech.2023.116119. View

13.

Cardoso M, Orozco R, Rezende S, Rodrigues G, Oshiro K, Candido E . Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates?. Front Microbiol. 2020; 10:3097. PMC: 6987251. DOI: 10.3389/fmicb.2019.03097. View

14.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

15.

Li C, Haratipour P, Lingeman R, Perry J, Gu L, Hickey R . Novel Peptide Therapeutic Approaches for Cancer Treatment. Cells. 2021; 10(11). PMC: 8616177. DOI: 10.3390/cells10112908. View

16.

Torres P, Sodero A, Jofily P, Silva-Jr F . Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019; 20(18). PMC: 6769580. DOI: 10.3390/ijms20184574. View

17.

Muttenthaler M, King G, Adams D, Alewood P . Trends in peptide drug discovery. Nat Rev Drug Discov. 2021; 20(4):309-325. DOI: 10.1038/s41573-020-00135-8. View

18.

Arif M, Musleh S, Fida H, Alam T . PLMACPred prediction of anticancer peptides based on protein language model and wavelet denoising transformation. Sci Rep. 2024; 14(1):16992. PMC: 11266708. DOI: 10.1038/s41598-024-67433-8. View

19.

Liang X, Zhao H, Wang J . MA-PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism. Protein Sci. 2024; 33(4):e4966. PMC: 10966354. DOI: 10.1002/pro.4966. View

20.

Wang D, Liu J, Li T, Wang Y, Liu X, Bai Y . A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy. Cell Death Discov. 2022; 8(1):411. PMC: 9537177. DOI: 10.1038/s41420-022-01198-9. View